Result of incentive program LTI2023 in Initiator Pharma

The AGM held on May 26, 2023 approved two long-term incentive programs (“LTI2023”), one for Management and leading employees and one for board members.

LTI2023 for Management and leading employees:
Under the program for Management and leading employees the board is authorized to allow participants in the program to acquire up to 108.500 ordinary shares in the market at market price (“Investment Shares”) until September 30, 2023, with each Investment Share carrying the right to subscribe for 1 new share at par value at the next AGM providing that the individual owning the Investment Share is still with the company at the time (“Matching Share”). Each Investment Share is also entitled to subscribe for between 0 and 5 new shares at par value during 30 trading days after December 31, 2025, depending on the development of Initiator’s share price in the period between May 26 2023 and December 31 2025. The maximum potential dilution under the approved program is 651,000 shares, representing approx. 1.2% of currently issued number of shares.

The board has decided to allocate a total of maximum 108.500 shares that can be purchased under this program, representing a potential dilution of 651.000 shares and approx. 1.20% of currently issued number of shares. By the end of the allowable investment period the maximum number of shares has been purchased in the market.

LTI2023 for Board members:
Under the program for Board members the board is authorised to allow participants in the program to acquire up to 23.000 ordinary shares in the market at market price (“Investment Shares”) until September 30, 2023, with each Investment Share carrying the right to acquire 1 new share from the company at par value at the next AGM providing that the individual owning the Investment Share is still with the company at the time (“Matching Share”). Each Investment Share is also entitled to acquire between 0 and 5 new shares from the company at par value during 30 trading days after December 31, 2025, depending on the development of Initiator’s share price in the period between May 26 2023 and December 31 2025. The maximum potential dilution under the approved program is 138,000 shares, representing approx. 0.3% of currently issued number of shares.

The board has decided to allocate a total of maximum 23.000 shares that can be purchased under this program, representing a potential dilution of 138.000 shares and approx. 0.3% of currently issued number of shares. By the end of the allowable investment period the maximum number of shares has been purchased in the market.

In the table below an overview of shares and warrants held by the board of directors, executive management and key employees is presented. The overview comprises warrants from the incentive programmes for 2021, 2022 and 2023, respectively.

Individual Position Shares Warrants Total
Shares and warrants
Pct
fully diluted
2021 2022 2023 Total
warrants
Magnus Persson Board member 267 186 50 000 12 500 48 000 110 500 377 686 0,72%
Henrik Moltke Board member 139 106 35 000 35 000 30 000 100 000 239 106 0,46%
Peter Holm Board member
Annette Colin Board member 25 000 35 000 15 000 30 000 80 000 105 000 0,20%
Gunilla Ekström Board member 19 000 35 000 30 000 65 000 84 000 0,16%
Total BoD 450 292 120 000 97 500 138 000 355 500 805 792 1,53%
Claus Olesen CEO and board member 1 137 438 300 000 175 000 180 000 655 000 1 792 438 3,42%
Other mgmt. and key employees 1 824 306 330 000 375 000 471 000 1 176 000 3 000 306 5,72%
Total Mgmt and key employees 3 964 038 630 000 550 000 651 000 1 831 000 4 792 744 9,14%
Total BoD, Mgmt and key employees 4 414 330 750 000 647 500 789 000 2 186 500 5 598 536 10,67%